Literature DB >> 18476168

Immune Sensitization to the 60 kD Heat Shock Protein and Pregnancy Outcome.

A Neuer1, S Spandorfer, P Giraldo, C Mele, H C Liu, K Marzusch, D Kneissl, S S Witkin.   

Abstract

Heat shock proteins are highly conserved proteins present in organisms ranging from bacteria to man. They are both dominant microbial immunogens and among the first proteins produced during mammalian embryo development. Since bacterial and human heat shock proteins share a high degree of amino acid sequence homology, it has been suggested that sensitization to bacterial heat shock proteins during an infection may result in autoimmunity to human heat shock proteins. Infertile couples seeking in vitro fertilization (IVF) may have been previously sensitized to bacterial heat shock proteins as a consequence of an asymptomatic upper genital tract infection. Due to daily clinical monitoring and precisely timed fertilization these patients are an ideal study group to investigate the effect of prior sensitization to heat shock proteins on preimplantation embryo development and implantation failure. Immune sensitization at the level of the cervix to the 60 kD heat shock protein (hsp60) has been associated with implantation failure in some IVF patients. Similarly, the highest prevalence of circulating hsp60 antibodies among IVF patients was found in the sera of women whose embryos failed to develop in vitro. To more directly assess whether humoral immunity to hsp60 influenced in vitro embryo development, a mouse embryo culture model was established. Monoclonal antibody to mammalian hsp60 markedly impaired mouse embryo development in vitro. These data suggest that immune sensitization to human hsp60, possibly developed as a consequence of infection, may adversely affect pregnancy outcome in some patients.

Entities:  

Year:  1997        PMID: 18476168      PMCID: PMC2364576          DOI: 10.1155/S1064744997000239

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  22 in total

Review 1.  Heat shock proteins and the immune response.

Authors:  S H Kaufmann
Journal:  Immunol Today       Date:  1990-04

2.  Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells.

Authors:  G Multhoff; C Botzler; L Jennen; J Schmidt; J Ellwart; R Issels
Journal:  J Immunol       Date:  1997-05-01       Impact factor: 5.422

3.  Recognition of trophoblasts by gamma delta T cells.

Authors:  K Heyborne; Y X Fu; A Nelson; A Farr; R O'Brien; W Born
Journal:  J Immunol       Date:  1994-10-01       Impact factor: 5.422

4.  Unsuspected Chlamydia trachomatis infection and in vitro fertilization outcome.

Authors:  S S Witkin; K M Sultan; G S Neal; J Jeremias; J A Grifo; Z Rosenwaks
Journal:  Am J Obstet Gynecol       Date:  1994-11       Impact factor: 8.661

5.  Immunomorphologic studies of human decidua-associated lymphoid cells in normal early pregnancy.

Authors:  L Mincheva-Nilsson; V Baranov; M M Yeung; S Hammarström; M L Hammarström
Journal:  J Immunol       Date:  1994-02-15       Impact factor: 5.422

6.  Heat shock proteins, first major products of zygotic gene activity in mouse embryo.

Authors:  O Bensaude; C Babinet; M Morange; F Jacob
Journal:  Nature       Date:  1983 Sep 22-28       Impact factor: 49.962

7.  Immunoelectron microscopic localization of the 60-kDa heat shock chaperonin protein (Hsp60) in mammalian cells.

Authors:  B J Soltys; R S Gupta
Journal:  Exp Cell Res       Date:  1996-01-10       Impact factor: 3.905

8.  Oocyte and zygote zona pellucida permeability to macromolecules.

Authors:  M Legge
Journal:  J Exp Zool       Date:  1995-02-01

9.  Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein.

Authors:  R P Morrison; R J Belland; K Lyng; H D Caldwell
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

10.  Expression of the HSP 70.1 gene, a landmark of early zygotic activity in the mouse embryo, is restricted to the first burst of transcription.

Authors:  E Christians; E Campion; E M Thompson; J P Renard
Journal:  Development       Date:  1995-01       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.